Boston Childrens Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT04107701
Investigators want to learn the role of indoor environmental exposures on respiratory symptoms, and, separately, on lung function deficits in school-aged children with bronchopulmonary dysplasia (BPD).
Looking for future studies?
Notify Me6 year–12 year
All sexes
Observational
Boston, Massachusetts, 02115, United States
Bronchopulmonary dysplasia (BPD) is the most common respiratory disease affecting children born prematurely and leads to long-term respiratory symptoms and lung function impairment throughout childhood. This study will, evaluate the contribution of indoor sources of respiratory irritants to respiratory health impairment in school-aged children with BPD. State-of-the-art measures of indoor air quality constituents will assess the relationship of nitrogen dioxide (NO2), particulate matter (PM2.5), as well as, concentrations of allergens (mold, mouse, cockroach, pet), endotoxin, air temperature and humidity with concurrently measured respiratory symptoms and lung function in a well-characterized cohort of children with BPD. This research will identify specific harmful components of the indoor environment associated with respiratory morbidity and poor lung function in children with BPD.
Investigators will ask the participants to come in for a one time clinic visit for undergoing procedures as well as answering questions regarding health and home environment. During the 1 year of participation there will also be 2 home assessment visits where investigators will take a sample of the home environment as well record home characteristics.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 weeks
maximum symptom days in the prior 2 weeks assessed at completion of home sampling visits ( Units: days scale: 0-14 days with symptoms, higher is worse
Time frame: 1 yr
Spirometry (FEV1 percent predicted) Units: percent Scale: continuous integers, higher is better
Time frame: 1 year
Oscillometry (R5-20)
Time frame: 1 year
Oscillometry (AX) units: cmH20 scale 0 - infinity, lower is better
Time frame: 1 year
Oscillometry R5 units: cmH20 scale 0 - infinity, lower is better
Time frame: 1 year
Oscillometry R5-20 units: cmH20 scale 0 - infinity, lower is better
Time frame: 1 year
Oscillometry X5 units: cmH20 scale 0 - infinity, lower is better
Time frame: 1 year
Oscillometry Fres units: Hz scale 0 - infinity, lower is better
Time frame: 1 year
FEV1/FVC units: percent scale: continuous integer, higher is better
Time frame: 1 year
FVC percent predicted units: percent scale: continuous integer, higher is better
Time frame: 1 year
FEF25-75 percent predicted units: percent scale: continuous integer, higher is better
Boston Children's Hospital
Other
Acronym: AeroBPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06110481
Bronchial Diseases, Bronchial Hyperreactivity
Prague, Czechia
View Trial DetailsNCT05404815
Behavior, Bronchopulmonary Dysplasia
Edegem, Antwerp, Belgium
View Trial DetailsNCT05898022
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Atlanta, Georgia, United States
View Trial DetailsNCT03540680
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Créteil, France
View Trial Details